Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on May 2, 2012, covering events occurring on May 1, 2012. The filing details material definitive agreements entered into to extend credit facilities and address liquidity covenants while the Company pursues a recapitalization plan.
Key Financial Metrics and Debt
- Outstanding Debt: As of April 30, 2012, the outstanding principal balance under the Amended Loan Agreement and Amended Ex-Im Agreement with Silicon Valley Bank was approximately $18.7 million.
- Cowen Facility: The outstanding principal under the loan agreement with Cowen Healthcare Royalty Partners II, L.P. is $15 million, secured by royalties from an alliance with Biosense Webster, Inc.
- Liquidity Covenant: The Company failed to comply with the minimum liquidity ratio financial covenant for the period ended April 30, 2012, resulting in a waiver from the Bank.
- Revenue and Profit: The filing text does not provide specific values for revenue, profit, cash flow, or margins.
Material Changes and Agreements
On May 1, 2012, the Company executed several amendments to extend maturity dates and waive defaults:
- Silicon Valley Bank Extension: The maturity of the revolving line of credit under the Amended Loan Agreement and the Amended Ex-Im Agreement was extended from April 30, 2012, to May 15, 2012.
- Covenant Waiver: The Bank waived defaults regarding the minimum liquidity ratio financial covenant for the compliance period ended April 30, 2012.
- Lender Extension: An amendment to the Note and Warrant Purchase Agreement extended the obligation of Alafi Capital Company LLC and affiliates of Sanderling Venture Partners to provide $10 million in direct loans or guarantees through May 15, 2012.
- Equity Issuance: In exchange for the extension, the Company granted warrants to purchase 609,756 shares of Common Stock at an exercise price of $0.41 per share.
- Cross-Default Waiver: The Company received a waiver of cross-defaults under its loan agreement with Cowen.
Outlook, Risks, and Management Commentary
Management states that these extensions were entered into to permit additional time to complete negotiations to strengthen the Company's capital position, including securing further extensions and completing additional capital transactions. While management believes its plans for recapitalization will be completed successfully, the filing explicitly states there can be no assurance that the Company will be able to finalize such recapitalization or that it will enable the execution of the current business plan.
Investor Verification Checklist
- Verify the status of the Company's ongoing recapitalization negotiations and whether the May 15, 2012 deadline was met.
- Confirm the current liquidity position and whether the minimum liquidity ratio covenant has been satisfied.
- Review the terms of the Extension Warrants issued to board-affiliated lenders (Alafi Capital and Sanderling Venture Partners).
- Assess the risk of further defaults if the $18.7 million Silicon Valley Bank facility and $15 million Cowen facility are not refinanced or repaid.